Members of Congress are increasingly leveraging their inside knowledge of forthcoming policy changes and economic ...

Shares of Tempus AI Inc (NASDAQ: TEM) are trading higher Wednesday, potentially building on momentum from last week given the ...

Years after its ChiNext debut, the medical device maker turns to Hong Kong’s market to fund its next expansion phase.

Industry representatives have voiced their support for the Biotech Act, hoping it will improve financing and institutional support of IVD makers.

Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare ...

The U.S. FDA issued a pair of final guidances this week, including one that outlines the criteria for authorizing emergency ...

One major change introduced by the EU MDR compared to the former European directives is the inclusion of products without an ...

Quality Control Market Size is projected to grow at a CAGR of 6.66 Market Research®. The report reveals that the market was ...

IVD devices enable earlier breast cancer diagnoses than mammograms, and detect genetic abnormalities that can contribute to ...

TEM secures FDA clearance for its xR IVD device, advancing RNA-based cancer research and precision medicine tools.

U.S.-based Tempus AI (TEM) stock is up in early trading on Monday. Yesterday, the company received FDA clearance for its ...